Introduction
Heat shock proteins (HSP) are highly conserved molecules that fulfill a range of functions, including cytoprotection and the intracellular assembly, folding, and translocation of oligomeric proteins [1] . Expression of these proteins can be induced by a range of cellular insults, which include high temperature, oxidative stress, viral infection, and nutritional deprivation [2] . Previous studies have demonstrated that increased expression of various HSP, such as HSP70, HSP60, HSP10, and HSP90, protected against stress insult. Recently, the cytoprotective properties of small HSP have drawn increased attention. Small HSP, including HSP20, HSP25, HSP27, αB-crystallin, and myotonic dystrophy kinase binding protein, are a group of proteins expressed in muscle tissues and share sequence homology of approximately 80-100 amino acids at the C terminus, known as the α crystallin domain [3, 4] . It was reported that overexpression of HSP27 by transfection into rodent and Chinese hamster cell lines directly correlated with survival from hyperthermia [5] [6] [7] . Overexpression of αB-crystallin has a similar effect [8] [9] [10] . It was also reported that overexpression of both HSP27 and αB-crystallin protected against ischemic injury in cardiac myocytes [11] . HSP20 is a newly discovered small HSP that was co-purified with αB-crystallin and HSP27 from skeletal muscle by affinity chromatography [12] . Previous reports demonstrated that HSP20 redistributed from the cytosol to insoluble fractions and dissociated from the aggregated form to the small form when rat diaphragm was exposed to heat stress in vitro [13] . Stable overexpression of HSP20 in Chinese hamster ovary cells results in enhanced survival after heat shock, which is similar to the results for αB-crystallin [14] . However, the effect of HSP20 on ischemia-mediated injury in cardiac myocytes has not been explored.
In our previous study, we showed that overexpression of HSP20 in rat heart in vivo protected against simulated ischemia/reperfusion (SI/R) injury, the mechanism of which related to the reduction of necrosis and apoptosis of ventricular cardiomyocytes (unpublished data). In the present
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Aim: To explore whether overexpression of the small heat shock protein HSP20 in rat cardiomyocytes protects against simulated ischemia/reperfusion (SI/R) injury. Methods: Recombinant adenovirus expressing HSP20 was used to infect rat H9c2 cardiomyocytes at high efficiency, as assessed by green fluorescent protein. H9c2 cells were subjected to SI/R stress; survival was estimated through assessment of lactate dehydrogenase and cell apoptosis through caspase-3 activity. 
Materials and methods

Construction of recombinant adenovirus
The recombinant adenovirus encoding HSP20 (Ad.HSP20) and adenovirus encoding GFP (Ad.GFP) were prepared as described previously [15] . Adenovirus was propagated in 293 cells and purified by 2 rounds of CsCl density ultracentrifugation (4 o C, 13000×g for 105 min and 16 h, respectively). Viral stocks were desalted through a PD-10 desalting column (Amersham Biosciences UK, Buckinghamshire, UK) into a Tris-buffered solution (10 mmol/L Tris, pH 8.0, 2 mmol/L MgCl 2 and 4% sucrose) [16] , plaque-titered, aliquoted, and stored at -80 o C with 4% sucrose until use.
Cell culture and simulated ischemia/reperfusion H9c2 cells were purchased from ATCC, the Global Bioresource Center (No CRl-1446; Hong Kong, China) and were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Cells were infected with Ad.HSP20 or Ad.GFP at a multiplicity of infection of 50 in no-serum DMEM when the confluence was 60%. After 2 h, the medium was removed and supplemented with DMEM containing 1% FBS for 24 h. Infected cells and the efficiency of infection were monitored by GFP expression with the use of fluorescent microscopy. After 24 h of infection, cells underwent 8 h of simulated ischemia and 24 h of reperfusion. Simulated ischemia was achieved by placing cells in a hypotonic balanced salt solution consisting of 4 , 69 mmol/L NaCl, 4 mmol/L NaHCO 3 , and 0.3 mmol/L Na 2 HPO 4 without glucose or serum, and hypoxia was induced for 8 h at 37 o C [17] . Hypoxia was attained with an airtight jar from which the oxygen was exhausted through the oxygen-consuming GasPak System from BBL Microbiology Systems (Cockeysville, MD) [17] . At the end of the experiment, the dishes were removed from the chamber with the medium, and cells were reperfused in noserum DMEM for 24 h. The control H9c2 cells were cultured in DMEM supplemented with 10% FBS, and cells were cultured in no-serum DMEM when the confluence was 60%. After 2 h, the medium was removed and cells were supplemented with DMEM containing 1% FBS. After 24 h, the medium was removed and cells were supplemented with a balanced salt solution at 37 o C for 8 h. The medium was then removed and the cells were cultured in no-serum DMEM for 24 h at 37 o C. The supernatant and cells were assayed separately for both lactate dehydrogenase (LDH) or caspase-3 activity.
Evaluation of necrosis and apoptosis by flow cytometry After SI/R, cells were harvested, washed, and doublestained using an annexin V-fluorescein-isothiocyanate (FITC) apoptosis detection kit. This kit is based on the observation that soon after initiating apoptosis most cell types translocate the membrane phospholipid phosphatidylserine from the inner face of the plasma membrane to the cell surface. Annexin V has a strong affinity for phosphatidylserine and therefore serves as a probe for detecting apoptosis. Cells that have lost membrane integrity will show red staining (propidium iodide) throughout the nucleus and therefore will be easily distinguishable from apoptotic cells. Samples were incubated for 15 min in the dark with annexin V and propidium iodide, and flow cytometry was carried out using a FACScan (Becton Dickinson, Heidelberg, Germany). Annexin V-FITC and propidium iodide-related fluorescence were recorded using FL1-H (525 nm) and FL2-H (575 nm) filters, respectively.
Lactate dehydrogenase (LDH) release assay Lactate dehydrogenase activity released into the medium or remaining in the cells was determined with the use of an LDH assay kit (Roche Diagnostics, Basel, Switzerland). The LDH activity is determined in an enzymatic test. In the first step, NAD + is reduced to NADH/H + by the LDH-catalyzed conversion of lactate to pyruvate. In the second step the catalyst transfers H/H + from NADH/H + to the tetrazolium salt INT, which is reduced to formazan, and the absorbance of the samples is measured at 490 nm using an enzyme-linked immunosorbent assay reader. Necrosis of cardiomyocytes was evaluated by the percentage of LDH release, which was calculated by the LDH activity in the medium divided by the total enzyme activity (medium and remaining activity in the cells) after reperfusion for 24 h.
Measurement of caspase-3 activity Cardiomyocytes were examined for apoptosis after simulated reperfusion for 24 h. Caspase-3 activity was determined by use of the caspase-3 Colorimetric Assay (R&D Systems, Minneapolis, MN, USA). Cells that were suspected to be or had been induced to undergo apoptosis were first lysed to collect their intracellular contents. The cell lysate was then tested for protease activity by the addition of a caspase-specific peptide that was conjugated to the color reporter molecule p-nitroanilide (p-NA). Cleavage of the peptide by caspase released the chromophore p-NA, which was quantitated spectrophotometrically at a wavelength of 405 nm.
Statistical analysis Data are expressed as mean±SD. Difference was analyzed for significance by one-way repeated-measures ANOVA and further analyzed with the use of the Newman-Keuls test for multiple comparisons between treatment groups. The results were considered significant at P<0.05.
Results
Gene transfer of Hsp20 inhibits necrosis and apoptosis of H9c2 cells
We infected H9c2 cells with Ad.HSP20 or Ad.GFP. The infection efficiency was 94.7% ± 2.1% (n=5) with Ad.HSP20 and 95.2%±2.6% (n=5) with Ad.GFP, as indicated by GFP fluorescence (Figure 1 ). Importantly, there was no apparent morphological alteration or difference in the number of adherent cells between control cells, Ad.HSP20-infected cells, and Ad.GFP-infected cells. We determined the levels of necrosis and apoptosis of H9c2 cells double-stained by annexin V-FITC and propidium iodide after SI/R by flow cytometry. The lower-left quadrants of the cytograms showed the viable cells, which excluded propidium iodide-stained cells and cells that were negative for annexin V-FITC binding. The lower-right quadrants represented the apoptotic cells, annexin V-FITC-positive cells, and propidium iodide-negative cells. The upper-right quadrants contained necrotic and lateapoptotic cells, positive for annexin V binding and for propidium iodide uptake. The upper-left quadrants represented cells damaged during the procedure. For each treatment group, 10 000 cells were analyzed. In the control group, most of the cells were healthy (93.0%) (Figure 2A ). Of the H9c2 cells exposed to SI/R, 22.3% were propidium iodide negative (lower-right quadrant) while 23.7% were propidium iodide positive (upper-right quadrant), which indicated early apoptosis and late apoptosis/necrosis, respectively ( Figure 2B ). Overexpression of HSP20 significantly reduced the number of cells labeled with annexin-V. The percentage of early apoptotic and late apoptotic/necrotic cells was significantly decreased to 5.1% and 1.0%, respectively ( Figure 2C ). H9c2 cells infected with control virus had no such result ( Figure 2D ).
We also detected necrosis and apoptosis by LDH release and caspase-3 activity, respectively. Cellular damage was measured by the amount of cytosolic LDH release after SI/R. Cell apoptosis was quantitated by caspase-3 activity. Overexpression of HSP20 in cardiomyocytes resulted in a 21.5% reduction in the proportion of cytosolic LDH release and a 58.8% reduction in caspase-3 activity, compared with Ad.GFP-treated cells ( Figure 3B) . 
Discussion
Our previous study demonstrated that overexpression of HSP20 in rat heart protected against ischemia/reperfusion, the protective effect relating to the reduction of necrosis and apoptosis of ventricular cardiomyocytes. In the present study, we used H9c2 cardiomyocytes, which originated from rat embryonic cardiac tissue and retained certain features of cardiac specificity [18, 19] , to investigate the mechanism of the protective effect of HSP20.
By detecting annexin V-FITC and propodium iodide double-stained H9c2 cells after SI/R by flow cytometry, we detected the necrosis and apoptosis of cells. We also de- tected the necrosis and apoptosis of H9c2 cells by LDH release and caspase-3 activity. Similar to the in vivo experiments, our results in vitro suggest that the protective effect of HSP20 also relates to the reduction of necrosis and apoptosis, which is indicated by flow cytometry, LDH re-lease and caspase-3 activity (unpublished data). Myocardial ischemia is frequently followed by reperfusion. Reperfusion and the resultant reoxygenation lead to the generation of oxygen radicals that can cause reperfusion injury. In the present study, we used H9c2 to mimic in vivo ischemia/reperfusion injury. We used LDH to evaluate the cell damage in vitro. The overexpression of HSP20 protected H9c2 cells against SI/R injury by reducing the LDH level. These data indicate that HSP20 reduces necrosis of cardiomyocytes. Our in vitro results also showed that H9c2 cells with overexpressed HSP20 had reduced caspase-3 activity. These data indicate that the antiapoptotic effect of HSP20 in cardiomyocytes is mediated through reduced caspase-3 activity. In addition, Fan et al [15] showed that the protective effects of HSP20 were further increased by the constitutively phosphorylated HSP20 mutant (S16D). In our study, the PKC inhibitor Ro-31-8220 (0.1 µmol/L) and selective mitochondrial K + ATP channel inhibitor 5-HD (100 µmol/L) blocked the HSP20-induced protective effect. Our results are similar to those of previous reports showing that the PKC inhibitor blocks the cardioprotective effect of the mitochondrial K + ATP channel [20, 21] , which indicates that PKC lies upstream of the mitochondrial K + ATP channel. Our results suggest that the protective effect of HSP20 is attributed to a reduction of necrosis and apoptosis in cardiomyocytes. Therefore, the cardioprotective effect of HSP20 in vitro might be mediated mainly by inhibiting cardiomyocyte necrotic and apoptotic cell death, possibly via the PKC/mito K + ATP pathway.
